United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Restaurant Industry News ViiV Healthcare bags Rukobia FDA approval for HIV patients with limited treatment options Rukobia FDA approval : ViiV Healthcare said that the US Food and Drug Administration (FDA) has approved Rukobia… bypharmanewsdailyJuly 4, 2020
